| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |